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1. Introduction 
Although our understanding of DNA methylation mechanisms and functions has vastly 
improved over the past two decades, the entire spectrum of influences of this potent 
mechanism is not fully grasped yet. Today, a wide variety of techniques are used to examine 
DNA methylation patterns but most of these methods are still relatively expensive and 
many are platform specific (Prokhortchouk and Defossez, 2008). The need has arisen to 
develop an economically viable and uncomplicated technique for DNA methylation 
analysis. The comet assay (single cell gel electrophoresis or SCGE) is a cost-effective, 
sensitive and simple technique which is traditionally used for analysing and quantifying 
DNA damage in individual cells (Azqueta, et al., 2011, Fairbairn, et al., 1995). By modifying 
this assay to be methylation sensitive, global DNA methylation can be routinely measured 
in cell cultures while simultaneously being able to deduce the integrity of the genetic 
material of the examined cells. The methylation sensitive comet assay was used to examine 
the effect of the accumulating metabolite, succinylacetone (SA), in hereditary Tyrosinemia 
type I (HT1), since hepatocellular carcinoma (HCC) frequently develops into this disease. 
2. The role of DNA methylation in maintaining genome stability  
DNA undergoes several modifications following each replication cycle of which DNA 
methylation is one. DNA methylation, as part of the epigenetic code, involves the addition 
of a methyl group to cytosine without altering the original DNA sequence. DNA 
methylation may take place on the number five carbon of the cytosine pyrimidine ring and 
this modification has been observed in every vertebrate examined (Herman, 2001, 
Waggoner, 2007). DNA methylation alters the biophysical characteristics of DNA which 
may either inhibit the recognition of certain DNA sequences by functional proteins or enable 
the binding of others (Prokhortchouk and Defossez, 2008). 
DNA methylation is carried out by a group of enzymes called DNA methyltransferases 
(DNMTs) (Pogribny, et al., 2004). These enzymes not only determine the DNA methylation 
patterns during early development, but are also responsible for copying these patterns to the 
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new strands formed during DNA replication. Based on their preferred DNA substrates, 
these enzymes can be divided into two different classes – maintenance enzymes (DNMT1) 
and de novo or pioneering enzymes (DNMT3A + B) (Sweatt, 2009). 
The maintenance methyltransferase DNMT1 is responsible for copying existing methylation 
patterns to newly replicated, hemimethylated DNA (Kanai, et al., 2003, Sweatt, 2009). 
DNMT1 is also associated with other epigenetic processes such as silencing gene 
transcription and is known to interact with histone deacetylase 1 and 2 (HDAC1/2) (Kanai, 
et al., 2003). While some studies have indicated that DNMT1 has some de novo methylation 
activity in vitro, there is no substantial evidence indicating that this is the case in vivo 
(Okano, et al., 1999). Due to the relation of DNMT1 with HDAC1 and 2, it directly affects 
gene transcription and chromatin structure. Although the identification of hemimethylated 
sequences by DNMTs are still a point of discussion and uncertainty, there is some evidence 
suggesting that DNMT1 may be recruited by UHRF1 which can bind to partially methylated 
DNA (Prokhortchouk and Defossez, 2008). In short, DNMT1 is the key maintenance DNA 
methyltransferases which is responsible for copying the previously established methylation 
blueprint after every replication cycle.  
The de novo methyltransferase DNMT3 typically establishes new DNA methylation patterns 
in specific regions, mainly in satellite repeats and retrotransposon (transposons via RNA 
intermediates) sequences (Gopalakrishnan, et al., 2008). The dnmt3 gene family consists of 
dnmt3a and dnmt3b which seems to have related functions (Okano et al, 1999). Studies done 
on rodent embryos lacking the dnmt3a showed that these embryos developed normally but 
died a few weeks after birth (Bird, 2002, Mohn and Schubeler, 2009). On the other hand, 
mice lacking dnmt3b suffered from multiple developmental defects and were aborted 
(Gopalakrishnan, et al., 2008, Mohn and Schubeler, 2009). This is not only a clear indication 
of the importance of DNMT3 in de novo methylation but also illustrates the fundamental role 
of DNA methylation in early development. To summarize, DNMT3A and B are responsible 
for methylating previously unmethylated DNA and seem to play an imperative role in 
development and growth.  
A fourth DNA methyltransferase, DNMT2, exists and is structurally similar to prokaryotic 
and eukaryotic methyltransferases. However, it shows weak or no DNA methyltransferase 
activity in vitro and targeted deletion of the DNMT2 gene in embryonic stem cells causes no 
detectable effect on global DNA methylation, suggesting that this enzyme has little 
involvement in establishing DNA methylation patterns (Okano et al, 1999; Klose, 2006). The 
methyltransferase DNMT3L is thought to be a co-factor for DNMT3a and DNMT3b and 
modulates their catalytic activity (Klose and Bird, 2006, Prokhortchouk and Defossez, 2008). 
S-adenosylmethionine (SAM) acts as a methyl donor and donates a methyl group to 
unmethylated cytosines within CpG islands of genomic DNA. The methyl group is 
transferred from SAM to the 5‘ position from cytosine through the actions of DNMTs.   
To summarize, DNMTs are at the core of the DNA methylation machinery and is not only 
responsible for establishing new methylation patterns in DNA but also to maintain these 
patterns after replication. It may even be an inseparable part of transcription.  Elucidating 
the full extent of influence of the DNMTs will undoubtedly better our understanding of 
DNA methylation and will be indispensable for future medical endeavours to ultimately 
prevent disease. 
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Maintaining global genome stability is crucial for the development and normal functioning 
of any organism. In eukaryotic organisms, DNA methylation is crucial for maintaining 
genome stability, as well as playing an important role in routine gene expression (Bird, 2002, 
Nag and Smerdon, 2009). Apart from ensuring a stable genome in adults, DNA methylation 
also plays a central role in the ordered differentiation of mammalian cells during embryonic 
development by activating specific genes and silencing others (Mohn and Schubeler, 2009). 
 Two common patterns of cytosine methylation at CpG dinucleotides have been described in 
the eukaryotic genome - genome-wide CpG methylation density, and non-random regional 
CpG methylation (Cottrell, 2004, Ohgane, et al., 2008). DNA methylation in adult somatic 
tissues typically occurs in regions called CpG islands while non-CpG methylation 
(methylation outside of CpG islands) is most prevalent in embryonic stem cells (Haines, et 
al., 2001). CpG islands are characterized by high CpG density and tend to be unmethylated 
under normal conditions (Duffy, et al., 2009).  
As part of the epigenetic code, DNA methylation ensures diverse cellular differentiation 
despite a primarily static genome. There exists a complex collaboration between epigenetic 
mechanisms (including DNA methylation, histone modification and micro RNA systems) to 
orchestrate a sophisticated and cell specific gene regulation (Guil and Esteller, 2009). These 
epigenetic processes connect the largely static genome and transcriptome by introducing 
complex and dynamic networking layers of gene control (Ohgane, et al., 2008). Due to this 
intensive involvement of DNA methylation in the epigenome, it comes as no surprise that 
the abnormal regulation of these mechanisms may cause altered gene expression and 
ultimately disease.  
3. Abnormal DNA methylation patterns associated with cancer 
Taken into account the crucial role epigenetics play in many cellular processes, it is logical 
that abnormal regulation of these mechanisms may lead to misinterpreted gene expression 
and eventually disease. This relationship between disease and the epigenome prompted 
scientists to perform comprehensive research into the role epigenetics play in the aetiology 
of these diseases. Today there is mounting evidence of irregular epigenetic regulation in 
many diseases (Gopalakrishnan, et al., 2008). 
In the late 1980s abnormal DNA methylation patterns were observed in  all cancer types 
investigated. There is ample  evidence indicating that disruption of epigenetically regulated 
expression of genes play a direct, and maybe even a causative, role in the development and 
manifestation of many diseases including cancer (Hirst and Marra, 2009, Sawan, et al., 2008). 
In cancer cells, methylated CpGs loose their DNA methylation status and unmethylated 
promoter regions may become densely methylated. This puzzling phenomenon prompted 
scientists to believe that both the loss and/or gain of DNA methylation are linked to cancer 
(Ehrlich, 2002, Gopalakrishnan, et al., 2008, Hirst and Marra, 2009). DNA methylation, as 
part of the epigenome, is critical in expanding and regulating the expression of the genome 
which in its turn  determines the phenotype. The epigenome is subsequently influenced by 
internal cues as well as a large range of environmental factors (Lambert and Herceg, 2008). If 
these processes are not  tightly regulated it can lead to changes in DNA methylation and 
histone modification patterns resulting in the disruption of important cellular processes 
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including  gene expression, DNA repair and tumour suppression - which may lead to cancer 
development. For instance, mutations in genes encoding for DNA methyltransferases lead 
to changes in  their expression and to altered DNA methylation patterns (Brenner, et al., 
2005). CpG islands are usually located in non-tissue specific promoter regions of genes and 
are normally unmethylated. Tumour cells exhibit global hypomethylation of the genome 
accompanied by region-specific hypermethylation (Szyf, 2006) (see figure 1).  
 
Fig. 1. Different methylation patterns in normal (A) and malignant (B) cells. Cancer cells 
exhibit global hypomethylation of the genome accompanied by region-specific 
hypermethylation. 
DNA hypomethylation can be described as the demethylation of the typically methylated 
regions of genes. The three main mechanisms proposed to contribute to cancer development 
due to hypomethylation is: (1) an increase in genomic instability, (2) reactivation of 
transposable elements and (3) loss of imprinting (Hirst and Marra, 2009). This may lead to 
the weakening, or even lifting, of the transcriptional repression in silenced gene promoters 
which in turn may contribute to the unwanted or abnormal expression of genes (Wilson, et 
al., 2007). This demethylation pattern can be seen in several cancers including metastatic 
hepatocellular cancer, cervical cancer, prostate tumours, and brain cancers (Das and Singal, 
2004). This abnormal demethylation can also cause chromosomal rearrangement and 
translocations which might negatively influence genome stability (Ehrlich, 2002).  
Hypermethylation of DNA is far more common in tumour cells than hypomethylation and 
mainly occurs in the promoter regions of genes leading to their transcriptional silencing 
(Moss and Wallrath, 2007). This is apparent from the inactivation of the tumour suppressor 
genes, adhesion molecules and repair enzymes which contribute to cancer development 
(Gopalakrishnan, et al., 2008). It has been confirmed that one or more genes are 
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hypermethylated in tumours. Examples of such studies are those concerning lung cancer 
(where over 40 genes were found to have altered methylation patterns) and leukaemia 
where many genes exhibit hypermethylation (Tsou, et al., 2002). CpG island 
hypermethylation also seems to increase in metastasis suppressor genes while increasing 
histone alterations (Lujambio and Esteller, 2007).   
Over the past decade studies have shown that epigenetic alterations are present in many 
malignancies and in contrast to genetic alterations, epigenetic changes are theoretically 
reversible - making them opportune targets for the development of therapeutic and 
preventive drugs. Better insight into the mechanisms involved in DNA methylation-related 
diseases are of cardinal importance for the development of more effective treatments.  
From this description of the crucial role DNA methylation plays in maintaining the integrity 
of the vertebrate genome, accurate measurement of the basic level of DNA methylation and 
deviations thereof become of paramount importance. Methods used to measure DNA 
methylation range from array technology to describe the methylome to evaluating the 
promoter assosiaded CpG islands of individual genes. The majority of the methods where 
global DNA methylation is investigated give a combined measure of DNA methylation of 
all the cells involved. The comet assay can be modified to measure DNA methylation of 
single cells. The advantages of this approach is that, because of the versatility of the comet 
assay, a spectrum of additional information pertaining to the integrity of the genome can be 
collected in one experiment e.g. DNA damage and repair.  
4. Using the methylation sensitive comet assay to investigate the role DNA 
methylation plays in hepatocellular carcinoma associated with tyrosinemia 
type 1 
4.1 Comet assay 
Presently, a wide variety of techniques are used to examine DNA methylation patterns, but 
most of these methods are relatively expensive and many are platform specific 
(Prokhortchouk and Defossez, 2008). The need has arisen to develop alternative and more 
economically viable techniques for DNA methylation analysis.  
The comet assay (or single cell gel electrophoresis assay) is a cost-effective, sensitive and 
simple technique, which is traditionally used for analysing and quantifying DNA damage in 
individual cells (Azqueta, et al., 2011, Fairbairn, et al., 1995). In 1984 Östling and Johanson 
developed the alkaline single cell gel electrophoresis assay as a novel approach for detecting 
DNA lesions. Today this method is regularly used in biomonitoring and mechanistic studies 
in a large range of in vitro and in vivo systems (Lovell and Omori, 2008). In this method, 
specific cells are harvested and encapsulated in a low melting point agarose gel. This gel 
solution is then applied to a glass slide covered in high melting point agarose.  
The agarose gel acts to keep the cells separate from each other and to serve as staging point 
for all the treatments that follow. Encapsulation is followed by chemical (usually a high salt 
concentration solution) lysis. The supercoiled DNA attached to the nuclear matrix unwinds 
due to the high pH (~12.3) of the alkaline lysing solution. The encapsulated nucleoids are 
now exposed to an electric current causing the damaged fragments of the DNA to migrate 
towards the anode - forming the so called tail of the comet. After electrophoresis, Tris-HCl is 
www.intechopen.com
 
DNA Methylation – From Genomics to Technology 
 
216 
used to neutralize the alkaline electrophoresis buffer followed by staining with ethidium 
bromide. Imaging software is then used to measure the fluorescence and to determine the 
extent of DNA damage (Collins, et al., 1997, Rojas, et al., 1999). The genomic integrity of the 
individual cell is then calculated by the tail migration by either measuring the tail length, 
tail moment or percentage DNA in the tail in (see figure 2 for an example of a comet) (Lovell 
and Omori, 2008). 
 
Fig. 2. The DNA fragments migrate from the nucleoid forming a comet like appearance. The 
general shape of a comet clearly indicating its head (nucleoid) and tail (migrated DNA) after 
electrophoresis and staining. 
The comet assay is widely used for genotoxicity studies and determining DNA repair 
capacity and a variety of DNA lesions can be detected using the alkaline version of the 
single cell gel electrophoresis (comet) assay, including DNA double (DSB) and single strand 
breaks (SSB), as well as alkali-labile sites (ALS) (Collins and Gaivao, 2007).The flexibility of 
the comet assay is further expanded with the use of specific restriction endonucleases. 
Modifications to the comet assay have allowed the use of lesion specific restriction enzymes 
to detect specific base modifications as DNA single strand breaks (Collins and Gaivao, 2007, 
Epe, et al., 1993). For example, Fpg acts both as an AP-lyase and a N-glycosylase, allowing it 
to release modified purines from double stranded DNA (Tice, et al., 2000). It was also shown 
that Fpg strongly enhances the detection of mitomycin C (MMC) and 
ethylmethanesulphonate (EMS) induced DNA modifications (Andersson and B.E.Hellman, 
2005). Damaged pyrimidines are removed in a similar manner from double stranded DNA 
by the endonuclease Endo lll (Speit, et al., 2009).  
By using methylation sensitive restriction endonucleases, the traditional alkaline comet 
assay can be modified to be methylation sensitive. This method enables the routine 
measurement of global, as well as CpG island DNA methylation in a variety of cells while 
simultaneously determining the genetic integrity of examined cells. 
4.2 Modification of the comet assay to be methylation sensitive 
The methylation sensitive comet assay employs the isoschizomeric restriction enzymes 
HpaII and MspI. These enzymes recognize the same tetranucleotide sequence (5’-C C G G-
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3’) but display differential sensitivity to DNA methylation. HpaII is inactive when any of the 
two cytosines is methylated, but it digests the hemimethylated 5’-CCGG-3’ at a lower rate 
compared with the unmethylated sequences. On the other hand, MspI digests 5’-CmCGG-3’ 
but not 5’-mCCGG-3’. These restriction enzymes features have been used to assess the global 
DNA methylation status of DNA preparations in radio labeling experiments (Fujiwara and 
Ito, 2002, Pogribny, et al., 2004). Difference in methylation sensitivity of the isoschizomeric 
restriction endonucleases Hpall and Mspl was also used to demonstrate the feasibility of the 
comet assay to measure global DNA methylation level in individual cells. Thus, when 
applied to the comet assay, one would expect that a higher level of DNA methylation of the 
CpG sequence in this site would result in a larger difference in the global amount of DNA in 
the comet tails of HpaII digested versus Msp I digested DNA.  
 
Fig. 3. A summary of the methylation sensitive comet assay method  
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4.2.1 Cell harvesting and repair 
One of the advantages of the comet assay is the possibility to employ a wide variety of cells, 
ranging from cultured cells to cells harvested in vivo. Different cell lines require specific 
cellular harvesting techniques, for instance, cultured HepG2 is an adherent cell line and 
must be separated from their growth chambers, adjacent cells and other material in 
suspension, while leucocytes have to be separated from other cells and substances present in 
blood. Many of the cultured cell lines require a proteinase harvesting step to detach them 
from the growth chamber and adjacent cells (see section 4.2.4). During this harvesting 
process, cells are exposed to trypsin which negatively influences the cell’s cellular integrity 
that may lead to DNA fragmentation. This makes a repair phase essential before the cells 
can be used in the comet assay. For recovery, cells were incubated in an orbital shaker (to 
prevent cells from adhering to the container) in DMEM nutrient medium for 2 hours at 37˚C 
directly after trypsin harvesting. In order to undergo electrophoresis to quantify the extent 
of DNA damage and/or fragmentation, cells must first be encapsulated in agarose gel. 
4.2.2 Cell encapsulation and lysis 
After the recovery phase, cells are encapsulated in a low melting point agarose gel and 
applied to a glass slide covered with a thin layer of high melting point agarose. In order for 
the comet assay to illustrate the integrity of a cell’s genetic material, the nucleoides must 
first be exposed.  The encapsulated cells are submerged in lysis solution consisting of 
sodium chloride (NaCl) [2.5 - 5M], ethylenediaminetetraacetic acid (EDTA), 10% dimethyl 
sulfoxide (DMSO) and 1% Triton X-100 at 4˚C. This solution is formulated to disrupt cellular 
material in the shortest amount of time, while leaving the nucleus unharmed. The high NaCl 
concentration draws water out of the cells by osmotic action. The exact NaCl concentration 
should be determined empirically for the specific type of cells used to prevent  it from 
negatively influencing the cell’s genomic integrity.  EDTA is commonly used to forage metal 
ions in order to deactivate metal dependant enzymes that may cause DNA damage. DMSO 
is an excellent polar aprotic solvent and is especially effective solvent in reactions involving 
salts. It acts as a hydroxyl radical scavenger formed when iron is released from blood while 
also acting to inhibit the formation of secondary DNA structures (Chakrabarti and Schutt, 
2001). Studies concluded that an 8-15% dilution of DMSO yields the best lysis results 
(Wentzel, unpublished M.Sc results). Finally, the non-ionic detergent Triton X-100 is used to 
solubilise cell proteins and membranes. 
4.2.3 Treatment of exposed nucleoids with restriction enzymes HpaII and MspI 
Nucleoids are treated with restriction enzymes HpaII and MspI just after the cell lysis step. 
In order to create favourable restriction conditions, the slides containing the nucleoids are 
soaked in enzyme reaction buffer for at least 10 minutes. The enzyme reaction buffer consist 
of 5x10-3 mol/l TrisHCl, 5x10-3 mol/l NaCl, 5x10-4 mol/l merkapto-ethanol  and 1x10-3 mol/l 
EDTA which is a close recreation of the Tango buffer usually used with these enzymes. 
Experiments have indicated that this composition of the reaction buffer is absolutely crucial 
for normal enzyme function and care should be taken in its accurate preparation. After the 
slides have been soaked in reaction buffer (and the excess liquid removed to prevent any 
negative affect it may have on the enzyme reaction) the enzyme mixture is directly applied 
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to the slides. Each enzyme mixture is composed of 1.5 unit of MspI or HpaII, 10 µl of Tango 
buffer (Fermentas) and filled to 100 µl with molecular grade H2O. 100 µl of this enzyme mix 
is then carefully applied to each slide and covered with a cover slip. The slides are then 
placed in a damp plastic container lined with towel paper that was preheated to 37˚C. After 
5 minutes of incubation the slides are covered with towel paper soaked in reaction buffer to 
keep the slides from drying out while incubating for another 55 minutes. In some cases, 
experimental results showed little or no DNA digestion. This may be the result of tightly 
packed nuclei where the majority of the enzymes recognition sites are unavailable, thus 
leading to poor DNA digestion. This can be overcome by treating the cells directly with a 
5% proteinase K solution just after lysis.  
 
Fig. 4. Comets created by the treating nucleoids with the isoschizomeric enzymes MspI and 
HpaII: Nucleoids without enzyme treatment (A), with MspI treatment (B), and with HpaII 
treatment (C). 
4.2.4 Proteinase K treatment of cells 
Nucleoids prepared from cells in the later phases of the growth curve (or even cells with a 
high passage number) tend to be tightly packed, making enzyme digestion only partially 
effective. As a last resort, this problem can be overcome by soaking the slides in 
electrophoresis buffer for 30 minutes just before enzyme treatment. This alkaline solution 
assists with unwinding the nucleus but can cause DNA damage leading to unwanted 
fragmentation. An alternative is to treat the cells with proteinase K (Qiagen) (1.0 -1.5 mM) 
solution which is a subtilisin-type protease. This broad spectrum serine protease is 
commonly used to inactivate nucleases when isolating or purifying DNA (QIAGEN, 2005). 
Proteinase K acts on the nucleosomes causing the DNA to relax and unwind, making 
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restriction enzyme recognition sites more accessible for MspI and HpaII (DNA-protein 
interactions that have survived the lysis step, are destroyed with this enzyme treatment). 
After proteinase K treatment there is a visible increase in the average tail percentage 
between the different enzyme digestions indicating the effectiveness of proteinase K in 
relaxing the nucleoids of HepG2tTS cells (see figure 5). Although the increase in DNA 
methylation was small, we observed these differences in several experiments And can also 
safely say that there was no DNase activity in the Proteinase K preparations The tail-DNA 
increase observed after restriction enzyme digestion in the  Proteinase K treated cells can 
thus be ascribed to an increase in the number of available restriction sites due to differences 
in DNA methylation sensitivity. 
 
Fig. 5. Proteinase K treatment of the nucleoids. The nucleoids were treated with Proteinase 
K before treatment with restriction enzymes. 
4.2.5 Investigation of DNA methylation within CpG islands using the methylation-
sensitive endonuclease NotI 
In adult somatic tissues DNA methylation typically occurs in regions called CpG islands. 
CpG islands are characterized by high CpG density and tend to be unmethylated under 
normal conditions (Duffy, et al., 2009). According to Gardiner-Garden sequence criteria, a 
CpG island is defined as a region greater than 200 bp with a G + C content greater than 50% 
(Gardiner-Garden and Frommer, 1987). Interestingly, over 40% of human genes contain 
CpG islands in their promoter regions and it is strongly believed that transcription 
activation and silencing of these genes are directly influenced by DNA methylation 
(Illingworth and Bird, 2009). To examine methylation in CpG islands, the methylation-
sensitive enzyme NotI can be used, since it has a 5’-GC^GGCCGC-3’ recognition site and 
acts mainly on target sites within CpG islands (Fazzari and Greally, 2004). Therefore, the  
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slides were soaked in restriction enzyme reaction buffer (50 mM Tris–HCl, 10 mM MgCl2, 
100 mM NaCl, and 0.1 mg/ml bovine serum albumin [BSA]) for 10 min. An enzyme mixture 
consisting of NotI (1.5 U/100 µl) in 1x Buffer O (Fermentas) was prepared, and 100 µl of this 
enzyme mixture was applied to the slides and covered with a coverslip. The comet assay 
was then performed as described above. 
4.2.6 Electrophoresis, staining and quantification of nucleoids 
After incubation, the slides are placed in an electrophoresis tank and covered with 
electrophoresis buffer (usually around 5 mol/l sodium hydroxide (NaOH) and 0.4 mol/l 
EDTA, pH 13). Electrophoresis is performed at a potential difference of 30V and a current of 
300mA for 45 minutes while the buffer is maintained at 4˚C. Experiments showed that 
electrophoresis at 4˚C is extremely crucial for optimum DNA fragment migration. After 
electrophoresis the slides are placed in a Tris-HCl neutralisation buffer for approximately 15 
minutes. This buffer acts to neutralize the alkaline electrophoresis and prevents it from 
causing unwanted DNA damage\fragmentation. The slides are then stained with 10µg/ml 
ethidiumbromide for at least an hour at 4˚C and rinsed afterwards with distilled water.  
Finally, the comet images are captured with a fluorescence microscope (x200 magnification) 
and scored using computer software (Comet IV from Perceptive Instruments Ltd). Due to 
intercellular variation, it is highly recommended that at least 200 comets are scored at 
random and that all experiments be done in duplicate. The data generated can then be 
analyzed and the results are expressed as percentage CpG methylation. This is calculated 
using the ratio between the average percentage tail DNA of HpaII- and MspI-digested DNA, 
that is, 100 – HpaII/MspI x 100, where HpaII and MspI are the average percentage tail DNA 
of HpaII- and MspI-digested nucleoids, respectively. To investigate the distribution 
properties of the percentage CpG methylation, the bootstrap analytical technique can be 
employed. The bootstrap is a technique that can estimate population parameters and 
distribution properties of statistics by substituting the population mechanism used to obtain 
the parameter with an empirical equivalent. These estimates can be obtained analytically, 
but they are obtained mostly through the use of resembling and Monte Carlo methods 
carried out by a computer (Wentzel, et al., 2010). 
4.2.7 Validation of methylation sensitive comet assay results 
To validate the results obtained with the comet assay, we performed the Cytosine Extension 
Assay (CEA) on the DNA isolated from the remaining cells of the same batch used for the 
comet assay. The CEA is also based on the selective use of the methylation-sensitive 
restriction enzymes HpaII and MspI, both of which leave a 5’ guanine overhang after DNA 
cleavage followed by a single nucleotide extension with [3H] dCTP (Pogribny et al, 2004). 
The level of radioactive cytosine incorporation is then determined by scintillation counting, 
and the methylation percentage can subsequently be calculated. 
The methylation-sensitive comet assay was applied to cultured cells that were treated with 
the metabolite succinylacetone (SA), which accumulates in hereditary tyrosinemia type I.  
Tyrosinemia is a genetic disorder characterized by elevated blood levels of the amino acid 
tyrosine. Type I tyrosinemia (HT1), the most severe form of tyrosinemia, is caused by a 
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defect of the enzyme fumarylacetoacetate hydrolase. Symptoms usually appear in the first 
few months of life and may include failure to thrive, diarhea, vomiting, jaundice and 
increased tendency to bleed. Type I tyrosinemia can lead to liver and kidney failure, 
problems affecting the nervous system, and an increased risk of liver cancer (Al-Dhalimy, 
2002; Orejuela, 2008). In a healthy liver, an enzyme mediated five-step process breaks down 
tyrosine into harmless molecules that are either excreted by the kidneys or used in energy 
the metabolism. Mutations in the fah gene cause a shortage of the enzyme 
Fumarylacetoacetate Hydrolase in this multistep pathway. This resulting enzyme deficiency 
leads to a toxic accumulation of tyrosine and its by-products, which can damage the liver, 
kidneys, nervous system and other organs and tissues. The exact cause of hepatocellular 
carcinoma associated with HT1 is unclear at the moment but it is speculated that some of the 
accumulating metabolites may have carcinogenic properties. 
4.3 Application of the methylation sensitive comet assay 
The HT1 metabolic defect leads to a toxic accumulation of tyrosine and its by-products, 
which can damage the liver, kidneys, nervous system, and other organs and tissues. The 
exact cause of hepatocellular carcinoma associated with HT1 is unclear at the moment but 
because there is some evidence indicating that HTI-accumulating metabolites may alter 
DNA methylation (Fazzari and Greally, 2004). There is some evidence suggesting that one of 
the accumulating metabolites of HT1, p-hydroxyphenylpyruvic acid or pHPPA, is 
responsible for the long-term impairment of the DNA repair, leading ultimately to cellular 
hepatocarcinoma (van Dyk and Pretorius, 2005). 
We examined the effect of another accumulating metabolite of HT1, succinylacetone (SA), 
on cultured liver cells using the metyhelation sensitive comet assay. The cultured cells were 
exposed to 50 uM SA for a period of 24 h, and the comet assay was performed. It was found 
that in contrast to a notable decline in DNA methylation outside the CpG islands of 
approximately 20% after 24 h of exposure to SA, an increase of approximately 8% in CpG 
island methylation was detected after SA treatment (see figure 6). These methylation 
patterns are typical of those observed in cancer cells (global demethylation and gene specific 
hypermethylation) and indicates that SA may indeed cause aberrant DNA methylation 
patterns in HTI, which can contribute to the initiation of hepatocarcinoma associated with 
this disease (Wentzel, et al., 2010).  
It is still not clear if the cell’s exposure to SA directly alters the DNA methylation profile, 
subsequently leading to cancer or if the change in DNA methylation is only a result of 
important disrupted cellular processes such as DNA repair mechanisms and tumour 
suppression – caused by the malignant state of the cell.  
5. Summary and conclusion 
Despite the progress that has been made to better our understanding of DNA methylation, it 
seems we are only at the first chapter of this intricate book and many unanswered questions 
remain surrounding the extent in which DNA methylation influences normal as well as 
malignant cell activity. One thing that can be said with certainty is that the main 
methylation function involves the regulation of gene expression. This function is extended 
via other actions, e.g. chromatin compaction, x-chromosome inactivation, maintaining  
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Fig. 6. DNA methylation of HepG2 cells treated with SA. Nucleoids digested with MspI and 
HpaII give an indication of DNA methylation outside the CpG islands, whereas NotI is used 
to determine DNA methylation in CpG islands. 
genome stability and maintaining cellular identity. These functions are, to a great extent, 
dependent on the physical properties of cytosine methylation and properly established and 
maintained DNA methylation patterns seems to be essential for mammalian development 
and normal functioning of the adult organism. 
According to the American Cancer Association nearly 13% of all deaths worldwide are 
cancer related. Currently, there are numerous publications suggesting that aberrant DNA 
methylation patterns play a direct, and likely causative, role in cancer initiation and 
development. Through better understanding of the role DNA methylation plays in cancer, 
we can develop more effective treatments for this devastating disease. 
The comet assay (single cell gel electrophoresis or SCGE) is a cost-effective, sensitive and 
simple technique which is traditionally used for analyzing and quantifying DNA damage in 
individual cells. A variety of DNA lesions can also be detected using the alkaline version of 
comet assay, including DNA double and single strand breaks (SSB), as well as alkali-labile 
sites. Modifications to the comet assay have allowed the use of lesion specific endonucleases 
to detect specific base modifications as DNA single strand breaks. 
Experiments with the methylation sensitive comet assay have shown that this technique can 
be successfully modified to determine changes in the level of global and regional DNA 
methylation of single cells. The study revealed that the hereditary tyrosinemia type I 
metabolite succinylacetone, may indeed cause DNA hypermethylation in HTI, which may 
contribute to the initiation of hepatocarcinoma associated with this disease. 
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Metabolic diseases can dramatically alter the metabolism of a cancer cell which can lead to 
dysfunctional electron transport chain, higher levels of reactive oxygen species and 
abnormal redox status. It is still unclear if metabolic alterations leads to epigenetic changes 
or vice versa, but it is apparent that the combination of these two modified states contribute 
to aberrant gene expression and cancer.  
The advantage of the comet assay above other methylation detection techniques is its cost 
effectiveness, ability to investigate the DNA integrity and the DNA methylation status of 
cells simultaneously, while being able to measure global as well as gene specific DNA 
methylation. This modification of the comet assay further expands the versatility of the 
comet assay by increasing the variety of observations that can be made in one experiment.  
One of the drawbacks of this technique is that the assay is very sensitive to external 
conditions and must be optimized to suite the specific laboratory setting. 
Because DNA methylation was shown to be a tissue-specific event (Pogribny, et al., 2004), 
this modification of the comet assay provides the opportunity to study the DNA 
methylation status of single cells that are prepared from different tissues under various 
physiological conditions. By applying the methylation sensitive comet assay to other cancer 
cell types the technology can be extended to investigate DNA methylation patterns in a 
variety of cancers.  
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